Behavioral changes with paranoia in an elderly woman taking atorvastatin

American Journal Geriatric Pharmacotherapy

Volumn 6, Issue 1, 2008, Pages 28-32

  Peters, Jessica T ^a   Garwood, Candice L ^a,b   Lepczyk, Marybeth ^b  

^a WAYNE STATE UNIVERSITY   (United States)

^b NONE

Author keywords

atorvastatin; behavior change; cognitive function; elderly; older adults; paranoia; statins

Indexed keywords

ACETYLSALICYLIC ACID; ALENDRONIC ACID; ATORVASTATIN; CALCIUM; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VITAMIN D;

AGED; ANXIETY; ARTICLE; BEHAVIOR CHANGE; CASE REPORT; DAILY LIFE ACTIVITY; DISEASE ASSOCIATION; DRUG WITHDRAWAL; ELDERLY CARE; FEMALE; FOOD INTAKE; GERIATRIC DEPRESSION SCALE; HUMAN; HUMAN RELATION; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIFE SATISFACTION; LIFESTYLE; MINI MENTAL STATE EXAMINATION; OSTEOPOROSIS; PARANOIA; PATIENT COMPLIANCE; PRIORITY JOURNAL; SHORT PORTABLE MENTAL STATUS QUESTIONNAIRE; SIDE EFFECT; SYMPTOM; VITAMIN SUPPLEMENTATION;

AGED; COGNITION; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PARANOID DISORDERS; PYRROLES; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 44249087165     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2008.03.001     Document Type: Article

References (16)

1. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
2. Orsi A., Sherman O., and Woldeselassie Z. Simvastatin-associated memory loss. Pharmacotherapy 21 (2001) 767-769
3. Galatti L., Polimeni G., Salvo F., et al. Short-term memory loss associated with rosuvastatin. Pharmacotherapy 26 (2006) 1190-1192
4. Padala K., Padala P., and Potter J. Simvastatin-induced decline in cognition. Ann Pharmacother 40 (2006) 1880-1883
5. King D., Wilburn A., Wofford M., et al. Cognitive impairment associated with atorvastatin and simvastatin. Pharmacotherapy 23 (2003) 1663-1667
6. Wagstaff L., Mitton M., Arvik B., and Doraiswamy P. Statin-associated memory loss: Analysis of 60 case reports and review of the literature. Pharmacotherapy 23 (2003) 871-880
7. Tatley M., and Savage R. Psychiatric adverse reactions with statins, fibrates and ezetimibe: Implications for the use of lipid-lowering agents. Drug Saf 30 (2007) 195-201
8. Trottier M. Statins and memory loss. Can Adverse Reaction Newsletter 15 (2005) 2
9. Naranjo C., Busto U., Sellers E., et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30 (1981) 239-245
10. Björkhem I., and Meaney S. Brain cholesterol: Long secret life behind a barrier. Arterioscler Thromb Vasc Biol 24 (2004) 806-815
11. Joshi H., Fakes M., and Serajuddin A. Differentiation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors by their relative lipophilicity. Pharmacy Pharmacol Comm 5 (1999) 269-273
12. Caballero J., and Nahata M. Do statins slow down Alzheimer's disease? A review. J Clin Pharm Ther 29 (2004) 209-213
13. Reiss A., Siller K., Rahman M., et al. Cholesterol in neurologic disorders of the elderly: Stroke and Alzheimer's disease. Neurobiol Aging 25 (2004) 977-989
14. Summers M., Oliver K., Coombes J., and Fassett R. Effect of atorvastatin on cognitive function in patients from the Lipid Lowering and Onset of Renal Disease (LORD) trial. Pharmacotherapy 27 (2007) 183-190
15. Elias P., Elias M., D'Agostino R., et al. Serum cholesterol and cognitive performance in the Framingham Heart Study. Psychosom Med 67 (2005) 24-30
16. Vevera J., Fisar Z., Kvasnicka T., et al. Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmission. Psychiatry Res 133 (2005) 197-203